企業プロフィール
MorphoSys 株価・ニュース・カタリスト
- ティッカー:
- MOR
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Germany and listed in the U
株価変動の要因
Current closing-price context is not available for MOR.
企業概要
事業概要
MorphoSys was a German antibody biotechnology company focused on oncology and immunology before its acquisition by Novartis. Its legacy value came from antibody discovery and partnered programs.
所在地とセクター分類
Headquartered in Germany and listed in the U.S. as an ADR before acquisition, MorphoSys was a global antibody-biotech name.
ビジネスモデルの特徴
The business relied on partnered assets, royalties, and internal oncology development rather than a broad commercial base.
バイオ業界での位置付け
MorphoSys was a premium antibody platform name and now belongs to biotech M&A history.
今後のカタリスト
- MorphoSys is now mostly a closeout story, so the catalysts are any remaining value-realization or legacy-asset update rather than a fresh pipeline milestone. The market is focused on what residual value is left.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。